Insider Trading July 9, 2026 06:21 PM

Concentrix CEO Purchases Shares Amid Earnings Miss and Downgraded Outlook

Christopher Caldwell's $21,249 stock acquisition occurs as the company reports Q2 results that slightly trail analyst expectations and revises full-year growth guidance lower.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
CNXC

Concentrix Corp (CNXC) President and CEO Christopher A. Caldwell purchased 1,000 shares of the company's common stock on July 8, 2026, totaling $21,249. The transaction follows a second-quarter earnings report that fell short of Wall Street forecasts and a downward revision to the company's full-year growth outlook. Despite the earnings miss, Caldwell's purchase comes as the stock trades near its 52-week low of $19.12, with the company appearing undervalued at 0.48 times book value according to InvestingPro data. Management has been actively repurchasing shares, and the company recently released its 2026 Sustainability Report, highlighting significant progress in emissions reduction.

Concentrix CEO Purchases Shares Amid Earnings Miss and Downgraded Outlook
CNXC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Concentrix CEO Christopher Caldwell purchased 1,000 shares at $21.2497 each, totaling $21,249, bringing his direct holdings to 358,382 shares.
  • The company reported Q2 non-GAAP earnings of $2.63 per share on $2.46 billion in revenue, missing Wall Street expectations of $2.64 per share and $2.47 billion in revenue.
  • Concentrix revised its full-year constant-currency growth forecast down to approximately 0.75% from 2.5%, prompting Canaccord to lower its price target to $45 while maintaining a Buy rating.
  • The stock trades near its 52-week low of $19.12, down 11% over the past week, while trading at 0.48 times book value, suggesting potential undervaluation.

Concentrix Corp (CNXC) President and CEO Christopher A. Caldwell acquired 1,000 shares of the company's common stock on July 8, 2026, according to a recent SEC filing. The transaction, valued at $21,249, was executed at a price of $21.2497 per share. Following this acquisition, Caldwell directly holds 358,382 shares of Concentrix Corp common stock.

The insider purchase arrives as the stock trades near its 52-week low of $19.12, having declined 11% over the past week. According to InvestingPro data, the company appears undervalued with shares trading at just 0.48 times book value. An InvestingPro Tip notes that management has been aggressively buying back shares. Investors can access 14 additional ProTips and a comprehensive Pro Research Report for CNXC on the platform.

In other recent news, Concentrix Corporation reported its fiscal second-quarter results, which slightly missed Wall Street expectations. The company posted non-GAAP earnings of $2.63 per share on revenue of $2.46 billion, falling short of forecasts for $2.64 per share and $2.47 billion in revenue. This minor earnings miss was accompanied by a more cautious full-year outlook, as management reduced its full-year constant-currency growth forecast to approximately 0.75% at the midpoint, down from around 2.5% previously projected. Canaccord responded by lowering its price target for Concentrix shares to $45 from $55, although it maintained a Buy rating.

Additionally, Concentrix released its 2026 Sustainability Report, highlighting a 25.7% reduction in absolute emissions compared to a 2019 baseline. The company aims for a 46.2% reduction by 2030. Despite these sustainability achievements, investors appeared more focused on the slower revenue growth and other market challenges. The company's second-quarter revenue growth was reported at just 0.6% year-over-year in constant currency, below the 1.5% growth it had guided to earlier in March.

Risks

  • Concentrix faces slower revenue growth, with Q2 constant-currency revenue growth at just 0.6% year-over-year, below the 1.5% guidance provided earlier in March.
  • The company's full-year growth outlook has been significantly reduced from 2.5% to approximately 0.75%, indicating potential challenges in maintaining momentum.
  • Investor focus remains on market challenges and slower revenue growth despite sustainability achievements, which may impact near-term stock performance.

More from Insider Trading

Abeona Therapeutics Executive Sells Stock to Cover Tax Obligations as Q1 Earnings Beat Jul 9, 2026 Abeona Therapeutics Executive Disposes of Shares to Cover Tax Liabilities Jul 9, 2026 Wrap Technologies Director Shulman Acquires Shares Amid Product Expansions Jul 9, 2026 WRAP Technologies CEO Scot Cohen Acquires Shares Amid Product Launches and Regulatory Clarity Jul 9, 2026 Energy Fuels CEO Ross Bhappu Acquires Nearly $1 Million in Stock Amid Strategic Expansion Jul 9, 2026